REGN in the 13F filings
Regeneron Pharmaceuticals · CUSIP 75886F107
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 35
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 22 listed it in both
- Shares listed
- 18,208,420
- combined, among listed positions
- Reported value
- $11.4bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 24 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -1,680,429.
Managers listing REGN in Q2 2026
35 of 35 holders
Largest increases and reductions, by shares
Increases
- Dodge & Coxexisting position · 4,871,137 shares now+412,899
- Arrowstreet Capital LPexisting position · 393,685 shares now+222,114
- Susquehanna International Group LLPexisting position · 180,219 shares now+149,599
- Voloridge Investment Management LLCexisting position · 163,963 shares now+148,599
- Man Group PLCexisting position · 436,956 shares now+121,744
Reductions
- Fidelity (FMR LLC)existing position · 831,964 shares now-686,228
- T. Rowe Price Associates Incexisting position · 1,529,709 shares now-647,818
- Capital World Investorsexisting position · 814,925 shares now-604,075
- Wellington Management Group LLPexisting position · 1,270,087 shares now-567,372
- Two Sigma Investments LPexisting position · 656,124 shares now-156,112
New positions and exits
New (2)
Exited (4)
- Capital Research Global Investorswas $79m
- Freestone Grove Partners LPwas $24m
- ExodusPoint Capital Management LPwas $2.9m
- Point72 Asset Management LPwas $1.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 20 | $8.0bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.8bn | n.a. | n.a. |
| Q4 2013 | 17 | $8.9bn | n.a. | n.a. |
| Q1 2014 | 18 | $8.8bn | n.a. | n.a. |
| Q2 2014 | 20 | $8.4bn | n.a. | n.a. |
| Q3 2014 | 22 | $10.7bn | n.a. | n.a. |
| Q4 2014 | 16 | $12.3bn | n.a. | n.a. |
| Q1 2015 | 18 | $13.2bn | n.a. | n.a. |
| Q2 2015 | 16 | $14.7bn | n.a. | n.a. |
| Q3 2015 | 21 | $12.9bn | n.a. | n.a. |
| Q4 2015 | 20 | $15.3bn | n.a. | n.a. |
| Q1 2016 | 24 | $11.3bn | n.a. | n.a. |
| Q2 2016 | 20 | $10.5bn | n.a. | n.a. |
| Q3 2016 | 18 | $12.0bn | n.a. | n.a. |
| Q4 2016 | 22 | $10.4bn | n.a. | n.a. |
| Q1 2017 | 18 | $10.3bn | n.a. | n.a. |
| Q2 2017 | 23 | $13.6bn | n.a. | n.a. |
| Q3 2017 | 21 | $11.6bn | n.a. | n.a. |
| Q4 2017 | 27 | $9.4bn | n.a. | n.a. |
| Q1 2018 | 27 | $8.5bn | n.a. | n.a. |
| Q2 2018 | 24 | $9.2bn | n.a. | n.a. |
| Q3 2018 | 27 | $10.8bn | n.a. | n.a. |
| Q4 2018 | 28 | $9.9bn | n.a. | n.a. |
| Q1 2019 | 28 | $10.4bn | n.a. | n.a. |
| Q2 2019 | 29 | $8.3bn | n.a. | n.a. |
| Q3 2019 | 24 | $7.1bn | n.a. | n.a. |
| Q4 2019 | 18 | $9.0bn | n.a. | n.a. |
| Q1 2020 | 27 | $13.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $19.8bn | n.a. | n.a. |
| Q3 2020 | 24 | $17.4bn | n.a. | n.a. |
| Q4 2020 | 26 | $15.2bn | n.a. | n.a. |
| Q1 2021 | 22 | $13.7bn | n.a. | n.a. |
| Q2 2021 | 27 | $15.3bn | n.a. | n.a. |
| Q3 2021 | 26 | $15.5bn | n.a. | n.a. |
| Q4 2021 | 28 | $16.3bn | n.a. | n.a. |
| Q1 2022 | 25 | $19.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $16.5bn | n.a. | n.a. |
| Q3 2022 | 24 | $19.0bn | n.a. | n.a. |
| Q4 2022 | 30 | $20.2bn | n.a. | n.a. |
| Q1 2023 | 32 | $22.3bn | n.a. | n.a. |
| Q2 2023 | 28 | $18.8bn | n.a. | n.a. |
| Q3 2023 | 26 | $21.1bn | n.a. | n.a. |
| Q4 2023 | 35 | $21.9bn | 22 | 14 |
| Q1 2024 | 28 | $23.6bn | 12 | 20 |
| Q2 2024 | 28 | $25.6bn | 15 | 15 |
| Q3 2024 | 31 | $25.0bn | 17 | 15 |
| Q4 2024 | 27 | $13.8bn | 17 | 12 |
| Q1 2025 | 29 | $12.2bn | 20 | 10 |
| Q2 2025 | 32 | $9.3bn | 24 | 10 |
| Q3 2025 | 33 | $10.1bn | 22 | 12 |
| Q4 2025 | 33 | $16.3bn | 20 | 23 |
| Q1 2026 | 24 | $15.2bn | 14 | 26 |
| Q2 2026 | 22 | $10.6bn | 24 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
REGN and LLY →REGN and JNJ →REGN and VRTX →Choose a stock to compare with REGN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own REGN, latest filings →Back to the 13F Explorer →